CA2163543A1 - Disposable extracorporeal conduit for blood constituent monitoring - Google Patents

Disposable extracorporeal conduit for blood constituent monitoring

Info

Publication number
CA2163543A1
CA2163543A1 CA002163543A CA2163543A CA2163543A1 CA 2163543 A1 CA2163543 A1 CA 2163543A1 CA 002163543 A CA002163543 A CA 002163543A CA 2163543 A CA2163543 A CA 2163543A CA 2163543 A1 CA2163543 A1 CA 2163543A1
Authority
CA
Canada
Prior art keywords
cuvette
radiation
fluid
blood
conduit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002163543A
Other languages
French (fr)
Other versions
CA2163543C (en
Inventor
Robert R. Steuer
David H. Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Medical Care Holdings Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2163543A1 publication Critical patent/CA2163543A1/en
Application granted granted Critical
Publication of CA2163543C publication Critical patent/CA2163543C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14535—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring haematocrit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14557—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted to extracorporeal circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6825—Hand
    • A61B5/6826—Finger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683—Means for maintaining contact with the body
    • A61B5/6838—Clamps or clips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6843—Monitoring or controlling sensor contact pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607—Regulation parameters
    • A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
    • A61M1/361—Physical characteristics of the blood, e.g. haematocrit, urea before treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607—Regulation parameters
    • A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
    • A61M1/3612—Physical characteristics of the blood, e.g. haematocrit, urea after treatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B07—SEPARATING SOLIDS FROM SOLIDS; SORTING
    • B07C—POSTAL SORTING; SORTING INDIVIDUAL ARTICLES, OR BULK MATERIAL FIT TO BE SORTED PIECE-MEAL, e.g. BY PICKING
    • B07C3/00—Sorting according to destination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N21/0303—Optical path conditioning in cuvettes, e.g. windows; adapted optical elements or systems; path modifying or adjustment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N2021/036—Cuvette constructions transformable, modifiable

Abstract

A disposable cuvette (10) through which passes pulsatile flowing blood. The cuvette (10) has a conduit with two opposed walls having a predetermined separation therebetween that varies with each pulse of the flowing blood.
A sealed air pocket damps the variation of the predetermined separation. The conduit is comprised of materials which permit passage therethrough of wavelengths of selected electromagnetic radiation. The radiation is emitted from a photoemitter (102) which, and after passing through the cuvette, is detected by a photodetector (104). The quantities of detected radiation are operated on by a computer (150) which uses a spectrophotometry technique to derive therefrom a blood constituent concentration value. Preferably, both the cuvette (10) and the spectrophotometry technique are used during hemodialysis to derive changes in the hematocrit value of the blood of a dialyzed patient, thereby to deduce therefrom changes in the blood volume of the patient during dialysis.

Claims (68)

1. A disposable fluid cuvette, defining a fluid passageway for containing and conducting therethrough a fluid flowing under pressure in a pulsatile fashion, comprising:
(a) an inlet;
(b) an outlet;
(c) a conduit, in fluid communication both between and with said inlet and outlet and being comprised of materials which permit transmission of at least two predetermined wavelengths of electromagnetic radiation therethrough, comprising:
(1) first and second opposed walls, having a predetermined separation therebetween, and constraining the pulsatile flowing fluid therebetween; and (2) a transducer means, located in said first wall of said conduit, for varying said predetermined separation responsive to pressure pulsations in the fluid.
2. The cuvette as defined in Claim 1, wherein said transducer means is comprised essentially of silicone and said second wall is comprised essentially of medical grade plastic.
3. The cuvette as defined in Claim 2, wherein said first and second walls have an opposing facing side that is essentially circular in shape.
4. The cuvette as defined in Claim 1, wherein the conduit further comprises means, responsive to pressure pulsations in the fluid, for damping the variations of the predetermined separation.
5. The cuvette as defined in Claim 1, wherein said conduit further comprises a third wall, said first wall being disposed between said second and third walls said third wall and said transducer means having a means, situated therebetween and responsive to pressure pulsations in the fluid, for damping the variations of the predetermined separation.
6. The cuvette as defined in Claim 5, wherein said damping means is a hermetically sealed chamber.
7. The cuvette as defined in Claim 5, wherein said first and second walls have an opposing facing side that is essentially circular in shape.
8. The cuvette as defined in Claim 5, wherein said third wall has a convex side facing a side of said first wall.
9. The cuvette as defined in Claim 8, wherein said second and third walls are essentially immobile with respect to said transducer means for each pulse of said pulsatile flowing blood.
10. The cuvette as defined in Claim 9, wherein first wall is comprised essentially of silicone.
11. The cuvette as defined in Claim 5, wherein said conduit means further comprises first second and third cylindrical members in contact one with the others;
said first member being essentially comprised of silicone and comprising said first wall;
said second member being essentially comprised of medical grade plastic and comprising said second wall;
said third member being essentially comprised of medical grade plastic and comprising said third wall.
12. The cuvette as defined in Claim 11, wherein an external ring-shaped surface extends from said first and third walls.
13. The cuvette as defined in Claim 1 wherein said at least two predetermined wavelengths of electromagnetic radiation comprise a first radiation wavelength of 780 nanometers to about 850 nanometers and a second radiation wavelength of about 1200 nanometers to about 1600 nanometers, and wherein said pulsatile flowing fluid is blood.
14. The cuvette as defined in Claim 1 wherein said at least two predetermined wavelengths of electromagnetic radiation comprise a first radiation wavelength of 520 nanometers to about 600 nanometers and a second radiation wavelength of about 1200 nanometers to about 1600 nanometers, and wherein said pulsatile flowing fluid is blood.
15. The cuvette as defined in Claim 13 wherein said conduit is comprised of materials which permit transmission of electromagnetic radiation therethrough of a third radiation wavelength being of 900 nanometers to about 1000 nanometers, and of a fourth radiation wavelength being of 600 nanometers to about 700 nanometers.
16. The cuvette as defined in Claim 14 wherein said conduit is comprised of materials which permit transmission of electromagnetic radiation therethrough of a third radiation wavelength being of 900 nanometers to about 1000 nanometers, and of a fourth radiation wavelength being of 600 nanometers to about 700 nanometers.
17. The cuvette as defined in Claim 1 wherein said transducer means is said first wall, and wherein for each pulse of said pulsatile flowing fluid, said first wall makes a resilient fluctuation and said second wall is essentially immobile.
18. The cuvette as defined in Claim 1 wherein said conduit has an essentially cylindrical shape with a vertical wall both outside of and in between said first and second walls, said fluid flowing in a pulsatile fashion in contact with both said vertical wall and said first and second walls.
19. The cuvette as defined in Claim 18 wherein the volume of said pulsatile flowing fluid in said conduit passing outside said first and second walls is greater than the volume of said pulsatile flowing fluid passing therebetween.
20. The cuvette as defined in Claim 18 wherein said first and second walls are essentially parallel.
21. The cuvette as defined in Claim 20 wherein said inlet and said outlet share a common longitudinal axis which is parallel to said first and second walls, and said cylindrical conduit has a longitudinal axis that is normal to the shared common longitudinal axis of said inlet and outlet.
22. The cuvette as defined in Claim 1 further comprising:
means, extending from said first wall, for receiving a photoemitter; and means, extending from said second wall, for receiving a photodetector.
23. The cuvette as defined in Claim 1 further comprising external ring-shaped surfaces extending from said first and second walls.
24. The cuvette as defined in Claim 1 wherein said first wall has a first external ring-shaped surface extending therefrom, said first external ring-shaped surface having a second external ring-shaped surface extending therefrom which is concentric to said first external ring-shaped surface, and said first and second ring-shaped surfaces each having an inner diameter, said inner diameter of said first ring-shaped surface being less than said innerdiameter of said second ring-shaped surface.
25. The cuvette as defined in Claim 24 wherein said second wall has an external ring-shaped surface extending therefrom having an inner diameter that is greater than the inner diameter of said first ring-shaped surface.
26. The cuvette as defined in Claim 25 wherein said external ring-shaped surface extending from said second wall is concentric with said first ring-shaped surface.
27. The cuvette as defined in Claim 1 wherein said conduit cyclically increases and decreases the volume of pulsatile flowing fluid therein with each pulse of said pulsatile flowing fluid.
28. The cuvette as defined in Claim 1 wherein each said inlet and said outlet further comprises a means for fixedly attaching thereat a catheter having a lumen therethrough in fluid communication with said conduit.
29. The cuvette as defined in Claim 28 wherein said means for fixedly attaching is a luer lock connector.
30. A disposable blood cuvette, defining a fluid passageway for containing and conducting therethrough blood flowing under pressure in a pulsatile fashion, comprising:
(a) an inlet;
(b) an outlet:
(c) a conduit, having an essentially cylindrical shape and being in fluid communication both between and with said inlet and outlet and being comprised of materials which permit transmission of at least two predetermined wavelengths of electromagnetic radiation therethrough, comprising:
(1) opposed first and second walls, having a predetermined separation therebetween, and constraining the pulsatile flowing blood therebetween, and wherein for each pulse of said pulsatile flowing blood said first wall makes a resilient fluctuation so as to vary said predetermined separation and said second wall is essentially immobile;
and (2) a vertical wall, situated both outside and in between said first and second walls, said blood flowing in a pulsatile fashion in contact with both said vertical wall and said first and second walls.
31. The cuvette as defined in Claim 30, wherein the conduit further comprises means for damping the resilient fluctuation of the first wall for each pulse of said pulsatile flowing blood.
32. The cuvette as defined in Claim 30, wherein said conduit further comprises a third wall, said first wall being disposed between said second and third walls,
33 said first and third walls having a means, situated therebetween, for damping the resilient fluctuation of the first wall for each pulse of said pulsatile flowing blood.

33. The cuvette as defined in 32, wherein said conduit means further comprises first, second and third cylindrical members in contact one with the others;
said first member being essentially comprised of silicone and comprising said first wall;
said second member being essentially comprised of medical grade plastic and comprising said second and vertical walls;
said third member being essentially comprised of medical grade plastic and comprising said third wall.
34. The cuvette as defined in Claim 30, wherein the volume of said pulsatile flowing blood in said conduit passing outside said first and second walls is greater than the volume of said pulsatile flowing blood passing therebetween.
35. The cuvette as defined in Claim 30 wherein said first wall has a first external ring-shaped surface extending therefrom, said first external ring-shaped surface having a second external ring-shaped surface extending therefrom which is concentric to said first external ring-shaped surface, and said first and second ring-shaped surfaces each having an inner diameter, said inner diameter of said first ring-shaped surface being less than said innerdiameter of said second ring-shaped surface.
36. The cuvette as defined in Claim 30 further comprising:
means, extending from said first wall, for receiving a photoemitter; and means, extending from said second wall, for receiving a photodetector.
37. The cuvette as defined in Claim 30 wherein said first and second walls are essentially parallel.
38. The cuvette as defined in Claim 37 wherein said inlet and said outlet share a common longitudinal axis which is parallel to said first and second walls, and said cylindrical conduit has a longitudinal axis that is normal to the shared common longitudinal axis of said inlet and outlet.
39. The cuvette as defined in Claim 30 further comprising external ring-shaped surfaces extending from said first and second walls.
40. The cuvette as defined in Claim 35 wherein said second wall has an external ring-shaped surface extending therefrom having an inner diameter that is greater than the inner diameter of said first ring-shaped surface.
41. The cuvette as defined in Claim 40 wherein said external ring-shaped surface extending from said second wall is concentric with said first ring-shaped surface.
42. The cuvette as defined in Claim 30 wherein said conduit cyclically increases and decreases the volume of pulsatile flowing fluid therein with each pulse of said pulsatile flowing fluid.
43. A disposable fluid cuvette, for defining a fluid passageway for containing and conducting therethrough a fluid flowing in a pulsatile fashion, comprising:
a first fluid conduit, having an inlet and an outlet and a lumen therebetween;
a second fluid conduit, comprised at least in part of materials essentially permitting transmission of at least two predetermined wavelengths of electromagnetic radiation therethrough, and comprising:
an inlet in fluid communication with the outlet of the first fluid conduit, means, in contact with said pulsatile flowing fluid, for making a resilient fluctuation with each pulse of said pulsatile flowing fluid in a direction essentially normal to the general direction of movement of the pulsatile flowing fluid; and an outlet;
a third fluid conduit, having an inlet and an outlet and a lumen therebetween, said inlet of said third fluid conduit being in fluid communication with the outlet of the second fluid conduit.
44. The cuvette as defined in Claim 43 wherein said second fluid conduit further comprises a cylinder having opposing closed first and second ends. said first end being said means for making a resilient fluctuation and said second end being immobile with each pulse of said pulsatile flowing fluid.
45. The cuvette as defined in Claim 43 wherein said second fluid conduit further comprises means, in contact with resilient fluctuation means, for damping the resilient fluctuation of said resilient fluctuation means with each pulse of said pulsatile flowing fluid.
46. The cuvette as defined in Claim 44 wherein said first and second ends are comprised of materials essentially permitting transmission therethrough of said at least two predetermined wavelengths of electromagnetic radiation.
47. The cuvette as defined in Claim 44 wherein said first fluid conduit and said second fluid conduit have a common longitudinal axis, and said cylinder has a longitudinal axis that is normal to the common longitudinal axis of said first and second fluid conduits.
48. The cuvette as defined in Claim 44 wherein said first end has a first external ring-shaped surface extending therefrom, said first external ring-shaped surface having a second external ring-shaped surface extending therefrom which is concentric to said first external ring-shaped surface, and said first and second external ring-shaped surfaces each having an inner diameter, said inner diameter of said first external ring-shaped surface being less than said inner diameter of said second external ring-shaped surface.
49. The cuvette as defined in Claim 48 wherein said second end has an external ring-shaped surface extending therefrom having an inner diameter that is greater than the inner diameter of said first external ring-shaped surface.
50. The cuvette as defined in Claim 49 wherein said external ring-shaped surface extending from said second end is concentric with said first external ring-shaped surface.
51. The cuvette as defined in Claim 44 wherein said cylinder further comprises a sidewall, situated both outside of and between said first and second ends, and wherein said pulsatile flowing fluid contacts said first and second ends and said sidewall of said cylinder.
52. The cuvette as defined in Claim 51 wherein the volume of said pulsatile flowing fluid in said second fluid conduit passing outside said first and second ends is greater than the volume of said pulsatile flowing fluid passing therebetween.
53. The cuvette as defined in Claim 43 wherein said second fluid conduit cyclically increases and decreases the volume of pulsatile flowing fluid therein with each pulse of said pulsatile flowing fluid.
54. A system for determining a concentration of a biologic constituent present in the blood of a patient undergoing a hemodialysis treatment, the hemodialysis treatment incorporating a dialyzer means for cleaning the blood of the patient, a pump means, and an input and an output catheter means for respectively conducting the blood of the patient from the patient to an input port of the dialyzer means and from an output port of the dialyzer means back to the patient, the pump means being for pumping the blood of the patient in a pulsatile fashion into the input port of the dialyzer through the input catheter means and out of the output port of the dialyzer means through the output catheter means.
the system comprising:
(a) a first spectrophotometry means for defining a blood flow path, for emitting radiation into the blood in the flow path, and for detecting radiation passing through both the blood and the flow path, comprising:
(1) cuvette means, in fluid communication with the dialyzer means, for defining a fluid passageway which contains and conducts therethrough the blood flowing in a pulsatile fashion, and comprising:
(A) an inlet;
(B) an outlet;
(C) a conduit, in fluid communication both between and with said inlet and outlet and being comprised of materials which permit transmission of electromagnetic radiation at a first and a second radiation wavelength therethrough, comprising:
(i) first and second opposed walls, having a predetermined separation therebetween. and constraining the pulsatile flowing fluid therebetween; and (ii) a transducer means, located in said first wall of said conduit, for varying said predetermined separation responsive to pressure pulsations in the fluid;
(2) emitter-sensor means for emitting radiation into the blood in the flow path, and for sensing radiation passing through both the blood and the cuvette means, comprising:
(A) emission means for directing radiation at said first and second wavelengths into the pulsatile flowing blood within the cuvette means, said emission means being situated so as to direct said radiation into the conduit of said cuvette means, said radiation directed by said emission means defining a directed radiation comprising:
(i) a first quantity of a radiation at said first radiation wavelength which, when directed into the flowing blood, ((a)) has a first extinguishment value which varies with the desired biologic constituent concentration in the flowing blood and ((b)) has a second extinguishment value which varies with the concentration of com-ponents other than the desired biologic constituent in the flowing blood, which second extinguish-ment value is at least ten times smaller than said first extinguishment value; and (ii) a first quantity of a radiation at said second radiation wavelength, distinct from said first wavelength, which, when directed into the flowing blood, ((a)) has a third extinguishment value which for varying concentrations in the flowing blood of the desired blood constituent is a non fixed multiple of said first extinguishment value and ((b)) has a fourth extinguishment value which varies with the concentration of com-ponents other than the desired biologic constituent in the flowing blood, which fourth extinguishment value is at least ten times greater than said second extinguishment value;
(B) detection means for detecting the portion of said directed radiation which passes through both said conduit of said cuvette means and the pulsatile flowing blood therein, said detection means being situated so as to detect said radiation passing through the conduit of said cuvette means, the detected portion of each said directed radiation comprising:
(i) a second quantity of a radiation at the first radiation wavelength, and (ii) a second quantity of a radiation at the second radiation wavelength; and (b) calculation means, in electrical communication with said first spectrophotometry means, for determining the desired biologic constituent concentration by operating on the second quantities of the first and second radiation wavelengths.
55. The system as defined in Claim 54, wherein the conduit further comprises means, responsive to pressure pulsations in the fluid, for damping the variations of the predetermined separation.
56. The system as defined in Claim 54, wherein said conduit further comprises a third wall, said first wall being disposed between said second and third walls, said third wall and said transducer means having a means, situated therebetween and responsive to pressure pulsations in the fluid, for damping the variations of the predetermined separation.
57. The system as defined in claim 56, wherein said second and third walls are essentially immobile with respect to said transducer means for each pulse of said pulsatile flowing blood.
58. A system as defined in claim 54, further comprising a second spectrophotometry means, in electrical communication with said calculation means, being situated in fluid communication with said output catheter means and downstream of said dialyzer means, said first spectrophotometry means being situated in fluid communication with said input catheter means and upstream of said dialyzer means, whereby said calculator means determines the desired biologic constituent concentration in the blood of the patient, both before and after the dialyzer means, by operating on the second quantities of the first and second radiation wavelengths respectively detected by the first and second spectrophotometry means.
59. A system as defined in claim 54, wherein the second radiation wavelength has a third extinguishment value substantially the same amount for oxyhemoglobin and for reduced hemoglobin in the flowing blood and has a fourth extinguishment value, which is approximately the same as said third extinguishment value for the plasma in the flowing blood.
60. A system as defined in claim 54, wherein the first radiation wavelength is in the range from about 780 nanometers to about 850 nanometers and the secondradiation wavelength is in the range from about 1200 nanometers to about 1600 nanometers.
61. A system as defined in claim 54, wherein the first radiation wavelength is in the range from about 520 nanometers to about 600 nanometers and the secondradiation wavelength is in the range from about 1200 nanometers to about 1600 nanometers.
62. A system as defined in claim 54, wherein the flowing blood includes a competing biologic constituent relative to the hemoglobin in the flowing blood, wherein:
(a) said directed radiation further comprises a first quantity of a radiation at a third radiation wavelength, distinct from said first and second radiation wavelengths and transmissive through the conduit of said cuvette means, and which, when directed into the flowing blood in said cuvette means, (1) has a fifth extinguishment value which varies with the competing biologic constituent concentration in the flowing blood, said fifth extinguishment value being at least five times greater than said second extinguishment value; and (2) has a sixth extinguishment value which varies with the concentration of components other than the competing biologic constituent concentration in the flowing blood;
(b) said detected portion of said directed radiation further comprises a second quantity of a radiation at the third radiation wavelength;

(c) said calculation means mathematically operating on the second quantities of the first, second, and third radiation wavelengths (1) such that the spatial, geometric, and tissue variations are elimination in each radiation wavelength; and (2) to compensate for the effect of the competing biologic constituent.
63. A system as defined in claim 62, wherein the third radiation wavelength is extinguished approximately the same amount by oxyhemoglobin and reduced hemoglobin in the flowing blood and is substantially extinguished by plasma in the flowing blood.
64. A system as defined in claim 62, wherein the third radiation wavelength is in the range from about 900 nanometers to about 1000 nanometers.
65. A system as defined in claim 62, wherein:
(a) said directed radiation further comprises a first quantity of a radiation at a fourth radiation wavelength, distinct from said first, second andthird radiation wavelengths and transmissive through the conduit of said cuvettemeans, which when directed into the flowing blood in said cuvette means;
(1) has a seventh extinguishment value which varies substantially with the oxyhemoglobin and reduced oxyhemoglobin concentrations in the flowing blood, and which (2) has an eighth extinguishment value, which is at least ten times smaller than said seventh extinguishment value for the plasma in the flowing blood;
(b) said detected portion of said directed radiation further comprises a second quantity of a radiation at the fourth radiation wavelength;
(c) and wherein said calculation means:
(1) mathematically operates on the second quantity of the fourth radiation wavelength such that the spatial, geometric, and tissue variations are eliminated in the fourth radiation wavelength, and (2) determines a blood oxygen saturation value which is independent of hematocrit by mathematically operating on the second quantities of the first, second, third, and fourth radiation wavelengths.
66. A system as defined in claim 65, wherein the fourth radiation wavelength is in the range from about 600 nanometers to about 700 nanometers.
67. A system as defined in claim 62, wherein:
(a) said directed radiation further comprises a first quantity of a radiation at a fourth radiation wavelength, distinct from said first, second andthird radiation wavelengths, which when directed into the flowing blood in said cuvette means, (1) has a seventh extinguishment value which varies substantially with the oxyhemoglobin and reduced hemoglobin concentrations in the flowing blood, and which (2) has an eighth extinguishment value, which is at least ten times smaller than said seventh extinguishment value for the plasma in the flowing blood;
(b) said detected portion of said directed radiation further comprises a second quantity of a radiation at the fourth radiation wavelength;
(c) and wherein said calculation means:
(1) mathematically operates on the second quantity of the fourth radiation wavelength such that the spatial, geometric, and tissue variations are eliminated in the fourth radiation wavelength; and (2) determines a blood oxygen saturation value which is independent of hematocrit by mathematically operating on the second quantities of the first, second, third, and fourth radiation wavelengths.
68. A system as defined in claim 67, wherein the fourth radiation wavelength is in the range from about 600 nanometers to about 700 nanometers.
CA2163543A 1993-05-24 1994-05-24 Disposable extracorporeal conduit for blood constituent monitoring Expired - Lifetime CA2163543C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/066,344 1993-05-24
US08/066,344 US5351686A (en) 1990-10-06 1993-05-24 Disposable extracorporeal conduit for blood constituent monitoring
PCT/US1994/005915 WO1994027495A1 (en) 1993-05-24 1994-05-24 Disposable extracorporeal conduit for blood constituent monitoring

Publications (2)

Publication Number Publication Date
CA2163543A1 true CA2163543A1 (en) 1994-12-08
CA2163543C CA2163543C (en) 2010-04-13

Family

ID=22068896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2163543A Expired - Lifetime CA2163543C (en) 1993-05-24 1994-05-24 Disposable extracorporeal conduit for blood constituent monitoring

Country Status (12)

Country Link
US (2) US5351686A (en)
EP (1) EP0700268B1 (en)
JP (1) JP3667333B2 (en)
KR (1) KR100313211B1 (en)
AT (1) ATE206897T1 (en)
AU (1) AU6958294A (en)
CA (1) CA2163543C (en)
DE (1) DE69428696T2 (en)
DK (1) DK0700268T3 (en)
ES (1) ES2165877T3 (en)
PT (1) PT700268E (en)
WO (1) WO1994027495A1 (en)

Families Citing this family (162)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948272A (en) * 1986-04-29 1999-09-07 Lemelson; Jerome H. System and method for detecting and neutralizing microorganisms in a fluid using a laser
US6725072B2 (en) 1990-10-06 2004-04-20 Hema Metrics, Inc. Sensor for transcutaneous measurement of vascular access blood flow
US6246894B1 (en) 1993-02-01 2001-06-12 In-Line Diagnostics Corporation System and method for measuring blood urea nitrogen, blood osmolarity, plasma free hemoglobin and tissue water content
US5476434A (en) * 1992-05-27 1995-12-19 Kalb; Irvin M. Female incontinence device including electronic sensors
DK88893D0 (en) * 1993-07-30 1993-07-30 Radiometer As A METHOD AND APPARATUS FOR DETERMINING THE CONTENT OF A CONSTITUENT OF BLOOD OF AN INDIVIDUAL
DE4424267C2 (en) * 1994-07-09 1996-07-11 Hewlett Packard Gmbh Device for the continuous acquisition of blood parameters
US6153109A (en) 1994-09-16 2000-11-28 Transonic Systmes, Inc. Method and apparatus to measure blood flow rate in hemodialysis shunts
US6514419B2 (en) 1994-09-16 2003-02-04 Transonic Systems, Inc. Method to measure blood flow and recirculation in hemodialysis shunts
JP3772189B2 (en) * 1995-06-09 2006-05-10 コンメド コーポレイション Sensor for optical measurement of blood oxygen saturation, measuring method thereof, and measuring apparatus thereof
US6240306B1 (en) 1995-08-09 2001-05-29 Rio Grande Medical Technologies, Inc. Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration
US6212424B1 (en) 1998-10-29 2001-04-03 Rio Grande Medical Technologies, Inc. Apparatus and method for determination of the adequacy of dialysis by non-invasive near-infrared spectroscopy
US5983120A (en) * 1995-10-23 1999-11-09 Cytometrics, Inc. Method and apparatus for reflected imaging analysis
WO1997015228A1 (en) * 1995-10-26 1997-05-01 Medisystems Technology Corporation Pressure measurement in blood treatment
US5978691A (en) * 1996-07-19 1999-11-02 Mills; Alexander Knight Device and method for noninvasive continuous determination of blood gases, pH, hemoglobin level, and oxygen content
IT1288767B1 (en) * 1996-10-18 1998-09-24 Hospal Dasco Spa METHOD OF DETERMINING THE VALUE OF THE RECIRCULATION OF A SUSPENSION SUBJECT TO TREATMENT.
JP3622984B2 (en) 1996-10-23 2005-02-23 イン―ライン ダイアグノスティックス コーポレイション Noninvasive measurement system of hemodynamics in hemodialysis shunt
US6090061A (en) * 1997-10-22 2000-07-18 In-Line Diagnostics Corporation Disposable extracorporeal conduit for blood constituent monitoring
US6117099A (en) * 1996-10-23 2000-09-12 In-Line Diagnostics Corporation System and method for noninvasive hemodynamic measurements in hemodialysis shunts
US6746415B1 (en) * 1996-10-23 2004-06-08 Hema Metrics, Inc. Method of blood constituent monitoring using improved disposable extracorporeal conduit
WO1998019592A1 (en) * 1996-11-01 1998-05-14 Rio Grande Medical Technologies, Inc. Dialysis monitoring method and apparatus
WO1998022798A2 (en) * 1996-11-22 1998-05-28 Therakos, Inc. Contaminant detector
US6043871A (en) * 1997-03-03 2000-03-28 Brigham Young University System and method for measuring blood platelet function
US5928180A (en) 1997-03-25 1999-07-27 Krivitski; Nikolai M. Method and apparatus for real time monitoring of blood volume in a filter
US7890158B2 (en) 2001-06-05 2011-02-15 Lumidigm, Inc. Apparatus and method of biometric determination using specialized optical spectroscopy systems
US6628809B1 (en) 1999-10-08 2003-09-30 Lumidigm, Inc. Apparatus and method for identification of individuals by near-infrared spectrum
US6804543B2 (en) 1998-02-05 2004-10-12 Hema Metrics, Inc. Sensor for transcutaneous measurement of vascular access blood flow
US6064474A (en) * 1998-02-06 2000-05-16 Optical Sensors, Inc. Optical measurement of blood hematocrit incorporating a self-calibration algorithm
US6694157B1 (en) 1998-02-10 2004-02-17 Daedalus I , L.L.C. Method and apparatus for determination of pH pCO2, hemoglobin, and hemoglobin oxygen saturation
US6041801A (en) 1998-07-01 2000-03-28 Deka Products Limited Partnership System and method for measuring when fluid has stopped flowing within a line
US6157041A (en) * 1998-10-13 2000-12-05 Rio Grande Medical Technologies, Inc. Methods and apparatus for tailoring spectroscopic calibration models
US6441388B1 (en) 1998-10-13 2002-08-27 Rio Grande Medical Technologies, Inc. Methods and apparatus for spectroscopic calibration model transfer
US7098037B2 (en) 1998-10-13 2006-08-29 Inlight Solutions, Inc. Accommodating subject and instrument variations in spectroscopic determinations
US6144444A (en) * 1998-11-06 2000-11-07 Medtronic Avecor Cardiovascular, Inc. Apparatus and method to determine blood parameters
SE9804142D0 (en) 1998-11-30 1998-11-30 Gambro Ab Method and device for providing a signal
US6905479B1 (en) * 1999-07-20 2005-06-14 Deka Products Limited Partnership Pumping cartridge having an integrated filter and method for filtering a fluid with the cartridge
US6877713B1 (en) 1999-07-20 2005-04-12 Deka Products Limited Partnership Tube occluder and method for occluding collapsible tubes
US6604908B1 (en) 1999-07-20 2003-08-12 Deka Products Limited Partnership Methods and systems for pulsed delivery of fluids from a pump
US6382923B1 (en) 1999-07-20 2002-05-07 Deka Products Ltd. Partnership Pump chamber having at least one spacer for inhibiting the pumping of a gas
US6416293B1 (en) 1999-07-20 2002-07-09 Deka Products Limited Partnership Pumping cartridge including a bypass valve and method for directing flow in a pumping cartridge
US6816605B2 (en) 1999-10-08 2004-11-09 Lumidigm, Inc. Methods and systems for biometric identification of individuals using linear optical spectroscopy
US6868739B1 (en) 1999-10-19 2005-03-22 Transonic Systems, Inc. Method and apparatus to measure blood flow by an introduced volume change
AU2000254395A1 (en) * 2000-06-02 2001-12-17 Hema Metrics, Inc System and method for measuring blood urea nitrogen, blood osmolarity, plasma free haemoglobin and tissue water content
US6554788B1 (en) * 2000-06-02 2003-04-29 Cobe Cardiovascular, Inc. Hematocrit sampling system
DE10047421C1 (en) * 2000-09-26 2003-01-02 Klaus Sodemann Method and device for ultrafiltration control in blood treatment methods
DE10051943B4 (en) 2000-10-19 2015-01-15 Fresenius Medical Care Deutschland Gmbh Method and device for pulse wave transit time determination and extracorporeal blood treatment device with such a device
US6706007B2 (en) * 2000-12-29 2004-03-16 Chf Solutions, Inc. Feedback control of ultrafiltration to prevent hypotension
US6746407B2 (en) * 2000-12-29 2004-06-08 Hema Metrics, Inc. Method of measuring transcutaneous access blood flow
ITTO20010189A1 (en) * 2001-03-02 2002-09-02 Gambro Dasco Spa METHOD FOR MEASURING THE CONCENTRATION OF HEMOGLOBIN IN THE BLOOD IN A CIRCUIT OF A DIALYSIS MACHINE, MEASURING DEVICE AND CIRCUIT P
ITMI20012828A1 (en) 2001-12-28 2003-06-28 Gambro Dasco Spa NON-INVASIVE DEVICE FOR THE DETECTION OF BLOOD TEMPERATURE IN A CIRCUIT FOR THE EXTRACORPOREAL BLOOD CIRCULATION AND APPARATUS
US7620212B1 (en) 2002-08-13 2009-11-17 Lumidigm, Inc. Electro-optical sensor
US7011631B2 (en) * 2003-01-21 2006-03-14 Hemonix, Inc. Noninvasive method of measuring blood density and hematocrit
US7147153B2 (en) 2003-04-04 2006-12-12 Lumidigm, Inc. Multispectral biometric sensor
US7460696B2 (en) 2004-06-01 2008-12-02 Lumidigm, Inc. Multispectral imaging biometrics
US7539330B2 (en) 2004-06-01 2009-05-26 Lumidigm, Inc. Multispectral liveness determination
US7751594B2 (en) 2003-04-04 2010-07-06 Lumidigm, Inc. White-light spectral biometric sensors
US7545963B2 (en) 2003-04-04 2009-06-09 Lumidigm, Inc. Texture-biometrics sensor
US7347365B2 (en) 2003-04-04 2008-03-25 Lumidigm, Inc. Combined total-internal-reflectance and tissue imaging systems and methods
US7668350B2 (en) 2003-04-04 2010-02-23 Lumidigm, Inc. Comparative texture analysis of tissue for biometric spoof detection
US7627151B2 (en) 2003-04-04 2009-12-01 Lumidigm, Inc. Systems and methods for improved biometric feature definition
US7394919B2 (en) 2004-06-01 2008-07-01 Lumidigm, Inc. Multispectral biometric imaging
US7662139B2 (en) 2003-10-30 2010-02-16 Deka Products Limited Partnership Pump cassette with spiking assembly
US7461968B2 (en) 2003-10-30 2008-12-09 Deka Products Limited Partnership System, device, and method for mixing liquids
US8158102B2 (en) 2003-10-30 2012-04-17 Deka Products Limited Partnership System, device, and method for mixing a substance with a liquid
US7263213B2 (en) 2003-12-11 2007-08-28 Lumidigm, Inc. Methods and systems for estimation of personal characteristics from biometric measurements
US8229185B2 (en) 2004-06-01 2012-07-24 Lumidigm, Inc. Hygienic biometric sensors
US7508965B2 (en) 2004-06-01 2009-03-24 Lumidigm, Inc. System and method for robust fingerprint acquisition
US20110163163A1 (en) * 2004-06-01 2011-07-07 Lumidigm, Inc. Multispectral barcode imaging
US8787630B2 (en) 2004-08-11 2014-07-22 Lumidigm, Inc. Multispectral barcode imaging
US7801338B2 (en) 2005-04-27 2010-09-21 Lumidigm, Inc. Multispectral biometric sensors
WO2007034396A2 (en) * 2005-09-20 2007-03-29 Philips Intellectual Property & Standards Gmbh Extracorporeal glucose sensor
CA2648803C (en) 2006-04-14 2017-06-20 Deka Products Limited Partnership Systems, devices and methods for fluid pumping, heat exchange, thermal sensing, and conductivity sensing
US7967022B2 (en) 2007-02-27 2011-06-28 Deka Products Limited Partnership Cassette system integrated apparatus
US10537671B2 (en) 2006-04-14 2020-01-21 Deka Products Limited Partnership Automated control mechanisms in a hemodialysis apparatus
DE102006025005B4 (en) * 2006-05-30 2009-06-04 Schwarzer Gmbh Device for determining the blood oxygen content
US7995808B2 (en) 2006-07-19 2011-08-09 Lumidigm, Inc. Contactless multispectral biometric capture
US8355545B2 (en) 2007-04-10 2013-01-15 Lumidigm, Inc. Biometric detection using spatial, temporal, and/or spectral techniques
US8175346B2 (en) 2006-07-19 2012-05-08 Lumidigm, Inc. Whole-hand multispectral biometric imaging
WO2008100329A2 (en) 2006-07-19 2008-08-21 Lumidigm, Inc. Multibiometric multispectral imager
US7804984B2 (en) 2006-07-31 2010-09-28 Lumidigm, Inc. Spatial-spectral fingerprint spoof detection
US7801339B2 (en) 2006-07-31 2010-09-21 Lumidigm, Inc. Biometrics with spatiospectral spoof detection
DE102006036920B3 (en) * 2006-08-04 2007-11-29 Nirlus Engineering Ag Measuring glucose concentration in pulsating blood involves determining concentration in first measurement cycle, repeating, measuring transmission, scattering for near infrared wavelengths, computing indicator value, comparing with table
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8425471B2 (en) 2007-02-27 2013-04-23 Deka Products Limited Partnership Reagent supply for a hemodialysis system
US8491184B2 (en) 2007-02-27 2013-07-23 Deka Products Limited Partnership Sensor apparatus systems, devices and methods
MX2009009215A (en) 2007-02-27 2009-12-04 Deka Products Lp Hemodialysis systems and methods.
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8409441B2 (en) 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US10463774B2 (en) 2007-02-27 2019-11-05 Deka Products Limited Partnership Control systems and methods for blood or fluid handling medical devices
US8357298B2 (en) 2007-02-27 2013-01-22 Deka Products Limited Partnership Hemodialysis systems and methods
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
WO2008134135A2 (en) 2007-03-21 2008-11-06 Lumidigm, Inc. Biometrics based on locally consistent features
KR100812249B1 (en) 2007-05-07 2008-03-10 제이에스엠헬스케어 주식회사 Device of measuring and monitoring a hemoglobin value through blood tube
WO2008136548A1 (en) * 2007-05-07 2008-11-13 Jsm Healthcare Inc Device of measuring and monitoring a hemoglobin value through blood tube
US8771508B2 (en) 2008-08-27 2014-07-08 Deka Products Limited Partnership Dialyzer cartridge mounting arrangement for a hemodialysis system
US8863772B2 (en) 2008-08-27 2014-10-21 Deka Products Limited Partnership Occluder for a medical infusion system
WO2009071102A1 (en) * 2007-12-04 2009-06-11 Tallinn University Of Technology Optical method and device for measuring concentrations of substances in biological fluids
US8494630B2 (en) 2008-01-18 2013-07-23 Cameron Health, Inc. Data manipulation following delivery of a cardiac stimulus in an implantable cardiac stimulus device
EP2335753B1 (en) 2008-01-23 2019-08-07 DEKA Products Limited Partnership Fluid line autoconnect apparatus for medical treatment system
US10201647B2 (en) 2008-01-23 2019-02-12 Deka Products Limited Partnership Medical treatment system and methods using a plurality of fluid lines
US8289514B2 (en) 2008-03-05 2012-10-16 Aggredyne, Inc. Systems for measuring properties of a physiological fluid suspension
CA2717442C (en) 2008-03-07 2017-11-07 Cameron Health, Inc. Accurate cardiac event detection in an implantable cardiac stimulus device
ES2386623T3 (en) 2008-05-07 2012-08-23 Cameron Health, Inc. Devices to accurately classify cardiac activity
US8536536B2 (en) 2008-11-04 2013-09-17 Ingenieros Matematicos Consultores Asociados, S.A. Method and system for measuring the concentration of different compounds present in particulate material
US8130369B2 (en) * 2008-11-05 2012-03-06 Fresenius Medical Care Holdings, Inc. Measuring hematocrit and estimating hemoglobin values with a non-invasive, optical blood monitoring system
US9370324B2 (en) * 2008-11-05 2016-06-21 Fresenius Medical Care Holdings, Inc. Hemodialysis patient data acquisition, management and analysis system
AT506798B1 (en) * 2009-01-13 2009-12-15 Smart Medical Solutions Gmbh DEVICE FOR MEASURING AT LEAST ONE PARAMETER OF AN ARTERIAL BLOOD TEST
DE102009013592B3 (en) * 2009-03-17 2011-02-24 Siemens Aktiengesellschaft Method for continuous analysis of body fluid of organ or vessel section of patient, involves coupling catheter with analysis unit, where catheter is introduced in organ or vessel section of patient
DE102009017304A1 (en) 2009-04-11 2010-10-21 Fresenius Medical Care Deutschland Gmbh Apparatus and method for measuring a blood component in blood for an extracorporeal blood treatment device
ITMI20090926A1 (en) * 2009-05-26 2010-11-27 Datamed Srl SYSTEM AND METHOD FOR SPECTROPHOTOMETRIC MEASUREMENTS OF BLOOD PARAMETERS.
US8731250B2 (en) 2009-08-26 2014-05-20 Lumidigm, Inc. Multiplexed biometric imaging
US8265737B2 (en) * 2009-10-27 2012-09-11 Cameron Health, Inc. Methods and devices for identifying overdetection of cardiac signals
CN104841030B (en) 2009-10-30 2017-10-31 德卡产品有限公司 For the apparatus and method for the disconnection for detecting intravascular access device
US8570149B2 (en) 2010-03-16 2013-10-29 Lumidigm, Inc. Biometric imaging using an optical adaptive interface
US9002655B2 (en) 2010-05-03 2015-04-07 Gambro Lundia Ab Medical apparatus for extracorporeal blood treatment and method for determining a blood parameter value in a medical apparatus thereof
EP4249964A3 (en) 2010-07-07 2023-10-25 DEKA Products Limited Partnership Medical treatment system and methods using a plurality of fluid lines
DE102010038428A1 (en) * 2010-07-26 2012-01-26 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Optical measuring system
JP5535002B2 (en) * 2010-08-13 2014-07-02 旭化成メディカル株式会社 Blood component concentration measuring device
US8333724B2 (en) * 2010-09-07 2012-12-18 Fresenius Medical Care Holdings, Inc. Low flow optical blood chamber
US8743354B2 (en) 2010-09-07 2014-06-03 Fresenius Medical Care Holdings, Inc. Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
US9194792B2 (en) 2010-09-07 2015-11-24 Fresenius Medical Care Holdings, Inc. Blood chamber for an optical blood monitoring system
US8517968B2 (en) 2011-02-25 2013-08-27 Fresenius Medical Care Holdings, Inc. Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
US8328748B2 (en) 2010-09-13 2012-12-11 Fresenius Medical Care Holdings, Inc. Off-axis blood chamber
US20120119101A1 (en) * 2010-11-12 2012-05-17 Endress + Hauser Conducta Gesellschaft Fur Mess-Und Regeltechnik Mbh + Co. Kg Miniature UV sensor utilizing a disposable flow cell
US9173988B2 (en) 2010-11-17 2015-11-03 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
CA2817148C (en) 2010-11-17 2017-07-18 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
EP2463795A1 (en) * 2010-12-09 2012-06-13 Fresenius Medical Care Deutschland GmbH A method for calculating or approximating one or more values representing parameters of a patient and devices
CN103796709B (en) 2011-02-25 2016-10-19 费森尤斯医疗控股股份有限公司 Optical blood monitoring system have cover sensor clip assembly and blood chamber
DE102011013002C5 (en) * 2011-03-04 2020-12-17 Optek-Danulat Gmbh Flow-through measuring cell
SG195155A1 (en) 2011-05-24 2013-12-30 Deka Products Lp Blood treatment systems and methods
SG10201809897VA (en) 2011-05-24 2018-12-28 Deka Products Lp Hemodialysis System
US9999717B2 (en) 2011-05-24 2018-06-19 Deka Products Limited Partnership Systems and methods for detecting vascular access disconnection
USD725261S1 (en) 2012-02-24 2015-03-24 Fresenius Medical Care Holdings, Inc. Blood flow chamber
US9364655B2 (en) 2012-05-24 2016-06-14 Deka Products Limited Partnership Flexible tubing occlusion assembly
KR101317824B1 (en) * 2012-09-06 2013-10-15 이동화 Method of processing physiological signal
CN105208928B (en) 2013-03-11 2018-10-19 卡梅伦保健公司 Implement the equipment of arrhythmia detection double standards
WO2014170985A1 (en) * 2013-04-18 2014-10-23 ニプロ株式会社 Fluid concentration measuring device
US9308306B2 (en) 2014-02-24 2016-04-12 Fresenius Medical Care Holdings, Inc. Self calibrating blood chamber
JP6621734B2 (en) * 2014-03-20 2019-12-18 ニプロ株式会社 Blood concentration measurement value calibration device
US10463306B2 (en) 2014-05-15 2019-11-05 Novalung Gmbh Medical measuring system and method for production of the measuring system
US10391227B2 (en) * 2014-05-15 2019-08-27 Novalung Gmbh Medico-technical measuring device and measuring method
US9554714B2 (en) 2014-08-14 2017-01-31 Cameron Health Inc. Use of detection profiles in an implantable medical device
CN106999061B (en) * 2014-09-12 2020-08-07 范德堡大学 Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (PIVA) and applications thereof
USD799031S1 (en) 2015-09-09 2017-10-03 Fresenius Medical Care Holdings, Inc. Blood flow chamber with directional arrow
NZ741377A (en) 2015-10-09 2022-02-25 Deka Products Lp Fluid pumping and bioreactor system
EP3159026A1 (en) 2015-10-23 2017-04-26 novalung GmbH Intermediate element for a medical extracorporeal fluid conduit, medical extracorporeal fluid system and method for measuring a gas contained in a fluid guided in a medical extracorporeal fluid system of the human or animal body
EP4067868A1 (en) * 2016-02-04 2022-10-05 Nova Biomedical Corporation A calibrating-light module
US9976946B2 (en) 2016-04-21 2018-05-22 Instrumentation Laboratory Company Optical flow cell and test head apparatus
US10288556B2 (en) 2016-04-21 2019-05-14 Instrumentation Laboratory Company Optical flow cell apparatus and method for reducing deflection of sample chamber
EP3471612B1 (en) * 2016-06-15 2023-12-27 Sorin Group Italia S.r.l. Devices for monitoring blood
US11299705B2 (en) 2016-11-07 2022-04-12 Deka Products Limited Partnership System and method for creating tissue
CN106668968A (en) * 2016-12-30 2017-05-17 北京迈淩医疗技术发展有限公司 Hematodialysis device capable of determining relative blood volume
US10094726B2 (en) 2017-02-01 2018-10-09 Honeywell International Inc. Membrane isolated, gel-filled force sensor
AU2018324422B2 (en) * 2017-09-01 2020-12-03 Instrumentation Laboratory Company Optical flow cell apparatus and method for reducing deflection of sample chamber
KR102437776B1 (en) 2017-09-26 2022-08-26 삼성전자주식회사 Apparatus for estimating biological component and operating method thereof
WO2020006549A1 (en) 2018-06-29 2020-01-02 University Of Maryland, Baltimore A system for nondestructive spectroscopic analysis of biologic specimens
JP7298244B2 (en) * 2019-03-28 2023-06-27 株式会社ジェイ・エム・エス Sensor clip and liquid component measuring device
EP3889578A1 (en) * 2020-04-01 2021-10-06 Sartorius Stedim Biotech GmbH Flow cell assembly and spectroscopy device assembly for use in a bioprocess
US11744930B2 (en) 2020-04-06 2023-09-05 Fresenius Medical Care Holdings, Inc. Intradialytic monitoring of hemodynamic status based on detection of oxygen signature phase shift
JP7019752B2 (en) * 2020-06-24 2022-02-15 ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータ Methods and devices for monitoring blood
EP4075119A1 (en) * 2021-04-15 2022-10-19 Fenwal, Inc. Adjustment of the thickness of a biological fluid being monitored by an optical detection assembly

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3638640A (en) * 1967-11-01 1972-02-01 Robert F Shaw Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths
SE361812B (en) * 1972-07-12 1973-11-19 Sie4Ens Elema Ab
JPS5524004A (en) * 1978-06-22 1980-02-20 Minolta Camera Kk Oxymeter
JPS56104646A (en) * 1980-01-25 1981-08-20 Minolta Camera Kk Optical analyzer for forming ratio of element contained in organism
US4770179A (en) * 1982-09-02 1988-09-13 Nellcor Incorporated Calibrated optical oximeter probe
US4653498A (en) * 1982-09-13 1987-03-31 Nellcor Incorporated Pulse oximeter monitor
US4685464A (en) * 1985-07-05 1987-08-11 Nellcor Incorporated Durable sensor for detecting optical pulses
JPS63111837A (en) * 1986-10-29 1988-05-17 日本光電工業株式会社 Apparatus for measuring concentration of light absorbing substance in blood
US4920972A (en) * 1987-01-27 1990-05-01 Medex, Inc. Gel-filled blood pressure transducer
US4821734A (en) * 1987-04-21 1989-04-18 Nihon Seimitsu Sokki Co., Ltd. Sphygmomanometer
DE3726524A1 (en) * 1987-08-10 1989-02-23 Fresenius Ag HAEMOGLOBIN DETECTOR
US4805623A (en) * 1987-09-04 1989-02-21 Vander Corporation Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment
US4825879A (en) * 1987-10-08 1989-05-02 Critkon, Inc. Pulse oximeter sensor
DE3810411A1 (en) * 1988-03-26 1989-10-12 Nicolay Gmbh DEVICE FOR FIXING A SENSOR, IN PARTICULAR A SENSOR FOR OXIMETRIC MEASUREMENTS
US4825872A (en) * 1988-08-05 1989-05-02 Critikon, Inc. Finger sensor for pulse oximetry system
US5101825A (en) * 1988-10-28 1992-04-07 Blackbox, Inc. Method for noninvasive intermittent and/or continuous hemoglobin, arterial oxygen content, and hematocrit determination
US5111817A (en) * 1988-12-29 1992-05-12 Medical Physics, Inc. Noninvasive system and method for enhanced arterial oxygen saturation determination and arterial blood pressure monitoring
US5054487A (en) * 1990-02-02 1991-10-08 Boston Advanced Technologies, Inc. Laser systems for material analysis based on reflectance ratio detection
DE4014591A1 (en) * 1990-05-07 1991-11-21 Berg Extrakorp Syst Medtech Damper for blood pressure measuring appts. - is integral with valve body in chamber closed by rubber-elastic diaphragm
US5066859A (en) * 1990-05-18 1991-11-19 Karkar Maurice N Hematocrit and oxygen saturation blood analyzer
US5158091A (en) * 1990-11-30 1992-10-27 Ivac Corporation Tonometry system for determining blood pressure
US5371020A (en) * 1991-09-19 1994-12-06 Radiometer A/S Method of photometric in vitro determination of the content of an analyte in a sample

Also Published As

Publication number Publication date
CA2163543C (en) 2010-04-13
EP0700268B1 (en) 2001-10-17
PT700268E (en) 2002-01-30
KR100313211B1 (en) 2001-12-28
WO1994027495A1 (en) 1994-12-08
ES2165877T3 (en) 2002-04-01
AU6958294A (en) 1994-12-20
EP0700268A1 (en) 1996-03-13
US5351686A (en) 1994-10-04
KR960702271A (en) 1996-04-27
DE69428696T2 (en) 2002-05-08
DE69428696D1 (en) 2001-11-22
JP3667333B2 (en) 2005-07-06
DK0700268T3 (en) 2001-11-26
EP0700268A4 (en) 1997-08-20
US5456253A (en) 1995-10-10
JPH09500721A (en) 1997-01-21
ATE206897T1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
CA2163543A1 (en) Disposable extracorporeal conduit for blood constituent monitoring
CA2717886C (en) An apparatus and a method for monitoring a vascular access
US6527728B2 (en) Process and device for determining the pulse transit time and extracorporeal hemotherapeutic arrangement with such a device
JP4261774B2 (en) Fluid conduit monitoring device
US9050420B2 (en) Device and method for monitoring a vascular access for an extracorporeal blood treatment
KR100990704B1 (en) A method for measuring hemoglobin concentration (hgb) in the blood in a circuit of a dialysis machine, measuring device and circuit for the application of the method
US9265872B2 (en) Device and method for measuring a blood constituent in blood for an extracorporeal blood treating device
WO2012033738A1 (en) Blood chamber for an optical blood monitoring system
US20090247926A1 (en) Method and device for detecting air in a fluid system, in particular in an extracorporeal blood circuit of a blood treatment device
JP6728043B2 (en) Method and apparatus for determining a correction factor for detecting hemolysis or for correcting the effect of hemolysis in hematocrit measurement
KR100832048B1 (en) Dialysis machine blood circulating circuit fitting
US20240075247A1 (en) Dual lumen catheter
JP2023007642A (en) extracorporeal circulation device
JP2023007641A (en) Liquid concentration measuring device and extracorporeal circulation device
Yalçınbaş et al. Use of Spectrum Medical M3 monitor in pediatric cardiac surgery: gaseous emboli monitoring in Capiox RX05 and Capiox FX05 oxygenators
CN108379680A (en) A kind of family apparatus for purifying blood

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140526